[PLX] YoY Quarter Result on 31-Mar-2014 [#Q1]

Stock
[PLX] Protalix BioTherapeutics, Inc.
Announcement Date
08-May-2014
Financial Year
2014
Quarter
31-Mar-2014 [#Q1]
Profit Trend
QoQ- 32.52%
YoY- -69.98%
Quarter Report
PLX's Result
PLX's Financial Summary
View:
Show?
Quarter Result
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
Revenue 2,889 679 5,097 7,383 3,968 3,728 6,000 -11.45%
PBT -59,148 -8,526 -5,972 -7,345 -4,321 0 -5,052 50.63%
Tax 2,087 314 28 38 0 -161 0 -
NP -59,148 -8,598 -5,972 -7,345 -4,321 -5,904 -5,052 50.63%
Tax Rate - - - - - - - -
Total Cost 62,037 9,277 11,069 14,728 8,289 9,632 11,052 33.27%
Ratio Analysis
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
NP Margin -2,047.35 -1,266.27 -117.17 -99.49 -108.90 -158.37 -84.20 70.12%
Per Share
31/03/17 31/03/16 31/03/15 31/03/14 31/03/13 31/03/12 31/03/11 CAGR
EPS -4.75 -0.09 -0.06 -0.08 -0.05 -0.07 -0.06 107.07%
EPS Diluted -4.75 -0.09 -0.06 -0.08 -0.05 -0.07 -0.06 107.07%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.